Workflow
日化护肤年报|逸仙电商连亏五年亏超65亿 上海家化营收、归母净利润增速双垫底
Xin Lang Zheng Quan·2025-05-16 07:37

Core Insights - The performance of the daily chemical skincare industry in 2024 is generally pessimistic, with only 6 out of 17 selected companies achieving both revenue and net profit growth [1][2][4] - Notably, 4 companies reported losses, including Yatsen E-commerce, Jiaheng Cosmetics, Furuida, and Shanghai Jahwa, with Yatsen E-commerce experiencing continuous losses since its IPO in 2020, totaling over 6.5 billion yuan in losses [1][2][4] Revenue and Profit Analysis - Among the 17 companies analyzed, 6 companies reported a decline in both revenue and net profit, including Qingsong Co., Kesi Co., Shuiyang Co., Furuida, and Huaxi Biological [4][5] - The companies with revenue and net profit growth include Jinbo Biological (revenue up 84.92%, net profit up 144.27%), Shangmei Co. (revenue up 62.1%), and Juzi Biological (revenue up 57.2%) [2][7][9] - Companies with revenue but no profit growth include Lafang Co. (revenue 889 million yuan, net profit down 36.84%), Beitaini (revenue 5.736 billion yuan, net profit down 33.53%), and Fulejia (revenue 2.017 billion yuan, net profit down 11.77%) [2][4] Losses Overview - Yatsen E-commerce reported total revenue of 3.393 billion yuan, a slight decline of 0.63%, with a net profit loss of 710 million yuan [5][6] - Shanghai Jahwa's revenue was 5.679 billion yuan, down 13.93%, with a net profit loss of 833 million yuan, marking a significant decline of 266.6% [5][6] - Jiaheng Cosmetics reported revenue of 923 million yuan, down 9.13%, with a net profit loss of 24 million yuan, a decline of 159% [5][6] Performance Rankings - The top three companies in revenue growth are Jinbo Biological, Shangmei Co., and Juzi Biological, with growth rates of 84.92%, 62.1%, and 57.2% respectively [7] - The bottom three in revenue growth are Shanghai Jahwa, Furuida, and Jiaheng Cosmetics, with declines of 13.93%, 13.02%, and 9.13% respectively [7] - In terms of net profit growth, the top three are Jinbo E-commerce, Shangmei Co., and Juzi Biological, with growth rates of 144.27%, 74%, and 42.4% respectively [9]